Literature DB >> 7798947

Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla.

F Katoh1, K Kitamura, H Niina, R Yamamoto, H Washimine, K Kangawa, Y Yamamoto, H Kobayashi, T Eto, A Wada.   

Abstract

In cultured bovine adrenal medullary cells, stimulation of nicotinic receptors by carbachol evoked the Ca(2+)-dependent exocytotic cosecretion of proadrenomedullin N-terminal 20 peptide (PAMP) (EC50 = 50.1 microM) and catecholamines (EC50 = 63.0 microM), with the molar ratio of PAMP/catecholamines secreted being equal to the ratio in the cells. Addition of PAMP [1-20]NH2 inhibited carbachol-induced 22Na+ influx via nicotinic receptors (IC50 = 2.5 microM in a noncompetitive manner and thereby reduced carbachol-induced 45Ca2+ influx via voltage-dependent Ca2+ channels (IC50 = 1.0 microM) and catecholamine secretion (IC50 = 1.6 microM). It did not alter high K(+)-induced 45Ca2+ influx via voltage-dependent Ca2+ channels or veratridine-induced 22Na+ influx via voltage-dependent Na+ channels. PAMP seems to be a novel antinicotinic peptide cosecreted with catecholamines by a Ca(2+)-dependent exocytosis in response to nicotinic receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798947     DOI: 10.1046/j.1471-4159.1995.64010459.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Genetic loss of proadrenomedullin N-terminal 20 peptide (PAMP) in mice is compatible with survival.

Authors:  Brooke C Matson; Manyu Li; Claire E Trincot; Elizabeth S Blakeney; Stephanie L Pierce; Kathleen M Caron
Journal:  Peptides       Date:  2018-12-08       Impact factor: 3.750

2.  Proadrenomedullin NH2-terminal 20 peptide inhibits the voltage-gated Ca2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC 12 cells.

Authors:  K Takano; N Yamashita; T Fujita
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  Adrenomedullin. Implications for hypertension research.

Authors:  K Kitamura; K Kangawa; H Matsuo; T Eto
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

4.  Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings.

Authors:  T Shimosawa; Y Ito; K Ando; K Kitamura; K Kangawa; T Fujita
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Adrenomedullin expression in the human endometrium.

Authors:  J B Laoag-Fernandez; T Otani; T Maruo
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

6.  Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel.

Authors:  W K Samson; T C Murphy; Z T Resch
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.